Swallowing function with current sensory stimulation for Parkinson's disea se

Conditions

Parkinson's Disease Parkinson's disease, neurodegenerative disease

Nakamori M, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Hiraoka A, Yoshikawa M, Nagasaki T, Shimizu Y, Mikami Y, Maruyama H.

2024-05-183 citations

10.1038/s41598-024-62460-x

Association between motor symptoms of Parkinson's disease and swallowing disorders.

Nakamori M, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Haruta A, Hiraoka A, Yoshikawa M, Nagasaki T, Mikami Y, Maruyama H.

2023-12-064 citations

10.1007/s10072-023-07238-1

Detailed findings of videofluoroscopic examination among patients with Parkinson's disease on the effect of cervical percutaneous interferential current stimulation

Masahiro Nakamori, Megumi Toko, Hidetada Yamada, Yuki Hayashi, Azusa Haruta et al. (13 authors)

Frontiers in Neurology2023-11-072 citations

10.3389/fneur.2023.1279161

Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson's disease.

Nakamori M, Shimizu Y, Takahashi T, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Hiraoka A, Yoshikawa M, Nagasaki T, Mikami Y, Maruyama H.

2023-10-103 citations

10.1016/j.jns.2023.120831

Impact of neck percutaneous interferential current sensory stimulation on swallowing function in patients with Parkinson's disease: A single-arm, open-label study protocol.

Nakamori M, Toko M, Yamada H, Hayashi Y, Yoshikawa K, Yoshikawa M, Nagasaki T, Hiraoka A, Shimizu Y, Mikami Y, Maruyama H.

2023-06-105 citations

10.1016/j.conctc.2023.101158

Interventions

Using low-frequency stimulation device

interferential current sensory stimulation, Parkinson's disease

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed as Parkinson's disease Hoehn Yahr stage is from 2 to 4 No change of levodopa during 1 month before the inclusion. Capable of visiting hospital twice a week

Exclusion criteria

Exclusion criteria: Using pacemaker or implantable cardioverter defi brillator Patients who is pregnant or will be pregnant Past history of head and neck cancer or surgery Active pneumonia Receiving rehabilitation of swallowing

Design outcomes

Primary

Measure	Time frame
Percentage of patients with normal coughing reflection by coughing test at the end of intervention	—

Secondary

Measure	Time frame
Percentage of patients with normal coughing reflection by coughing test after 8 weeks from the end of intervention. Increment of provocative rate during 30 seconds after starting the coughing test at the end of intervention and after 8 weeks from the end of intervention. Percentage of patients with normal swallowing function at the end of intervention and after 8 weeks from the end of intervention. Reduction of aspiration or laryngeal penetration analyzed by swallowing videofluorography at the end of intervention and after 8 weeks from the end of intervention. Presence of pneumonia during the whole period.	—

Measure

Time frame

Percentage of patients with normal coughing reflection by coughing test after 8 weeks from the end of intervention. Increment of provocative rate during 30 seconds after starting the coughing test at the end of intervention and after 8 weeks from the end of intervention. Percentage of patients with normal swallowing function at the end of intervention and after 8 weeks from the end of intervention. Reduction of aspiration or laryngeal penetration analyzed by swallowing videofluorography at the end of intervention and after 8 weeks from the end of intervention. Presence of pneumonia during the whole period.

—

Contacts

Public ContactMasahiro Nakamori

Hiroshima University Hospital

mnakamori1@gmail.com+81-82-257-5201

Outcome results

None listed